Ken Ludlum
CIK 1255825 · Chief Financial Officer · last filed 2024-12-09
Ken Ludlum is a Chief Financial Officer who has filed 42 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider was granted $75.0K of DHAIW on Dec 9, 2024. Across all open-market trades the lifetime net is −$1.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BABY price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DIH HOLDING US, INC. (DHAIW) Delisted | Director | 52,817 | $0.00 | $164 | $0 | 1 | 2024-12-09 |
| IRIX | Director | 101,711 | $0.77 | $78.1K | $0 | 6 | 2023-06-15 |
| PSNL | Director | 113,506 | $15.90 | $1.80M | $786.6K | 6 | 2022-05-19 |
| NATUS MEDICAL INC (NTUS) Delisted | Director | 39,406 | $32.96 | $1.30M | -$403.5K | 1 | 2019-08-02 |
| NATUS MEDICAL INC (BABY) Delisted | Director | 52,038 | — | — | -$2.14M | 24 | 2019-07-02 |
| CDNA | Chief Financial Officer | 50,000 | $70.74 | $3.54M | $70.0K | 3 | 2016-01-26 |
Recent Filings
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-09 | DIH HOLDING US, INC. (DHAIW) Delisted | Grant (A) | +52,817 | $75.0K | EDGAR |
| 2023-06-15 | IRIX | Grant (A) | +39,267 | $75.0K | EDGAR |
| 2022-06-16 | IRIX | Grant (A) | +27,472 | $0 | EDGAR |
| 2022-05-19 | PSNL | Grant (A) | +10,770 | $0 | EDGAR |
| 2021-06-21 | IRIX | Grant (A) | +5,420 | $0 | EDGAR |
| 2021-05-18 | PSNL | Grant (A) | +2,736 | $0 | EDGAR |
| 2020-08-18 | PSNL | Sell (S) | −20,000 | -$403.4K | EDGAR |
| 2020-06-26 | IRIX | Grant (A) | +18,348 | $0 | EDGAR |
| 2020-05-19 | PSNL | Grant (A) | — | $0 | EDGAR |
| 2020-02-11 | PSNL | Exer (M) | +4,167 | $15.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.